COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA
Oral supplementation with Lenidase showed similar efficacy to aflibercept monotherapy in diabetic macular edema, with fewer injections, potentially reducing treatment burden.
Authors
- Teresio Avitabile (ORCID: https://orcid.org/0000-0002-2966-4981)
- Guglielmo Parisi (ORCID: https://orcid.org/0000-0003-0795-618X)
- Enrico Borrelli (ORCID: https://orcid.org/0000-0003-2815-5031)
- Giovanni Li Volti (ORCID: https://orcid.org/0000-0002-8678-2183)
- Ugo de Sanctis (ORCID: https://orcid.org/0000-0003-2852-305X)
- Lorenzo Motta (ORCID: https://orcid.org/0000-0002-7326-6024)
- Mario Damiano Toro (ORCID: https://orcid.org/0000-0001-7152-2613)
- Paola Marolo (ORCID: https://orcid.org/0000-0002-8881-0926)
- Michele Reibaldi (ORCID: https://orcid.org/0000-0003-1368-6729)
- Matteo Fallico (ORCID: https://orcid.org/0000-0003-2639-1321)
- Antonio Longo (ORCID: https://orcid.org/0000-0002-9525-1800)
- Andrea Russo (ORCID: https://orcid.org/0009-0009-7420-3576)
- Anna Nicolosi
Institutions
- Medical University of Lublin (PL)
- University of Padua (IT)
- University of Catania (IT)
- Federico II University Hospital (IT)
- Ospedale Cannizzaro (IT)
- University of Turin (IT)
Publication Details
- Journal
- Retina
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1097/iae.0000000000004427
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71